Seth Warhaftig brings to November Research Group more than 12 years of experience providing software solutions and services in the life science industry. He possesses a thorough knowledge of the drug development process, specifically in the areas of safety and pharmacovigilance, and clinical development and data management. His experience includes strategic planning, business process optimization, global regulatory compliance, custom system design and development, and system implementation and integration.

Prior to founding November Research Group, Seth was employed as a Safety and Clinical Solution Specialist for Oracle Corporation, the Executive Director of Worldwide Business Development for NetForce, Inc., and a Senior Consultant for Ernst & Young, LLP. Seth also held the positions of Director of Pharmaceutical and Biotechnology Consulting Services for NetForce, leading a 20 person services group, and Oracle Clinical Development Manager for Oracle Corporation.


Patrick Bagley • Senior Director

Patrick Bagley has played a role in completing every major Oracle AERS (Adverse Event Reporting System) implementation to date. His expertise includes user requirement gathering, business process reengineering, application configuration, training, and legacy data conversion.

Prior to joining November Research Group, Patrick spent seven years in the Pharmaceutical and Biotechnology industry followed by six years in safety application development and implementation. His former companies include Oracle Corporation, where he performed Oracle AERS implementations and trained Oracle AERS consultants, NetForce, Inc., and Xoma Corporation.


Brad Gallien • Senior Director

Brad Gallien brings to November Research Group more than 18 years of experience in clinical research and development, both within industry and as a software and services provider. He has an overall view of the entire product lifecycle, with specific expertise in clinical data management and pharmacovigilance. His experience includes strategic planning, business process optimization, global regulatory compliance, custom system design and development, and system implementation and integration.

Prior to joining November Research Group in October 2005, Brad was employed as the Director of Life Sciences Industry Strategy at Oracle Corporation, the Vice President at NetForce, Inc., and a Manager of Software Systems Support at Syntex. Mr. Gallien also held the positions of Director of Product Management for Oracle AERS for Oracle and various positions in clinical data management and biostatistics at Syntex.


Raul Inchausti • Senior Director

Raul Inchausti brings to November Research Group more than 19 years of experience providing software solutions and services. He possesses a thorough knowledge of the R&D development process, specifically in the areas of safety and pharmacovigilance, regulatory affairs. His experience includes strategic planning, project management, business process reengineering, and system implementation and integration. Raul has managed/participated in over 8 AERS implementations, Custom Safety System development and administration including the first ever E2B Submission to the EMEA as well as ARISg implementation/migrations.

Prior to November Research Group, Raul was co-founder of LSWorks, which assisted companies with their Pharmacovigilance needs. Prior to LSWorks he was employed by Oracle Corporation as a Senior Principal Consultant, Associate director Global Pharmacovigilance at BMS, Internal Consultant for Pfizer/Warner Lambert in support of the Medical and Regulatory department, Senior Information Analyst Electronic Data Systems supporting Billing and Collections systems for AT&T New Jersey, Telefonica SPAIN, and CANTV Venezuela.


Alan Summer • Senior Director

Alan Summer brings to November Research Group more than 17 years of experience in the IT industry, which has provided him with experience in all phases of the full-development cycle. Alan's strong management and technical background provide him with the knowledge and skills required to consistently deliver successful solutions on many platforms. For the past nine years, his focus has been on delivering solutions for the Pharmaceutical and Biotech industries. His expertise includes project management, user requirement gathering, business process re-engineering, application configuration, training, and legacy data conversion.

Prior to joining November Research Group, Alan co-founded LSWorks, which assisted companies with their Pharmacovigilance needs. Before LSWorks, he was employed by Oracle Corporation as a Senior Principal Consultant where he managed and implemented numerous AERS projects. He also managed several ARISg implementations as a Senior Technical Consultant at First Consulting Group (FCG) and was employed by AT&T as a Senior Developer for a Global Call Center system.


Aston Ying • Director

Aston Ying has played a role in completing over 20 major Oracle AERS (Adverse Event Reporting System) implementations to date. His expertise includes user requirement gathering, business process reengineering, application configuration, training, and system implementation and integration.

Aston brings to November Research Group six years of experience in Information Technology and 5 years in the Pharmaceutical and Biotechnology industry. Prior to joining November Research Group, he was a Senior Consultant at both BioPharm Systems and Oracle Corporation, and a Consultant at NetForce, Inc.